KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 133 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,579 | +6.5% | 20,814 | -34.2% | 0.00% | 0.0% |
| Q1 2023 | $340,435 | -3.8% | 31,639 | +34.0% | 0.00% | 0.0% |
| Q4 2022 | $353,737 | +35.5% | 23,614 | +16.0% | 0.00% | 0.0% |
| Q3 2022 | $261,000 | +107.1% | 20,361 | +89.6% | 0.00% | – |
| Q4 2021 | $126,000 | -22.7% | 10,740 | -25.6% | 0.00% | – |
| Q3 2021 | $163,000 | -20.1% | 14,439 | -1.7% | 0.00% | – |
| Q2 2021 | $204,000 | -31.1% | 14,689 | -8.3% | 0.00% | -100.0% |
| Q1 2021 | $296,000 | +678.9% | 16,017 | +628.0% | 0.00% | – |
| Q4 2020 | $38,000 | +15.2% | 2,200 | 0.0% | 0.00% | – |
| Q3 2020 | $33,000 | -41.1% | 2,200 | 0.0% | 0.00% | – |
| Q2 2020 | $56,000 | +64.7% | 2,200 | 0.0% | 0.00% | – |
| Q1 2020 | $34,000 | – | 2,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |